Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Saxton, John M ^a   Zwierska, Irena ^a   Mathur, Atish ^b   Channer, Kevin S ^b  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUSTANON 100; TESTOSTERONE; AUTACOID; CELL ADHESION MOLECULE;

ADJUVANT THERAPY; ADULT; AEROBIC EXERCISE; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; FEASIBILITY STUDY; FUNCTIONAL STATUS; HEART FAILURE; HEART FUNCTION TEST; HUMAN; HYPOGONADISM; MALE; MUSCLE CONTRACTION; MUSCLE FUNCTION; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATIENT SAFETY; PHYSICAL CAPACITY; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; WALKING; BLOOD; COMORBIDITY; ENDURANCE; EXERCISE TEST; EXERCISE TOLERANCE; HEALTH STATUS; KINESIOTHERAPY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CELL ADHESION MOLECULES; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; COMORBIDITY; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; HEALTH STATUS; HEART FAILURE; HUMANS; HYPOGONADISM; INFLAMMATION MEDIATORS; MALE; PHYSICAL ENDURANCE; PILOT PROJECTS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TESTOSTERONE;

EID: 33845638763     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-46     Document Type: Article

References (18)

1. Pugh PJ, Jones RD, Jones TH, Channer KS: Heart failure as an inflammatory condition: potential role for androgens as immune modulators. Eur J Heart Fail 2002, 4:673-680.
2. Kontoleon PE, nastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP, Nanas JN: Hormonal profile in patients with congestive heart failure. Int J Cardiol 2003, 87:179-183.
3. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS: Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 2006, 27:10-12.
4. Tappler B, Katz M: Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol (Oxf) 1979, 10:219-226.
5. Pugh PJ, Jones TH, Channer KS: Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J 2003, 24:909-915.
6. Tamaki T, Uchiyama S, Uchiyama Y, Akatsuka A, Roy RR, Edgerton VR: Anabolic steroids increase exercise tolerance. Am J Physiol Endocrinol Metab 2001, 280:E973-E981.
7. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS: Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004, 90:871-876.
8. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH: The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004, 89:3313-3318.
9. Recommendations for exercise training in chronic heart failure patients. Eur Heart J 2001, 22:125-135.
10. Gordon A, Tyni-Lenne R, Persson H, Kaijser L, Hultman E, Sylven C: Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure. Clin Cardiol 1996, 19:568-574.
11. Pu CT, Johnson MT, Forman DE, Hausdorff JM, Roubenoff R, Foldvari M, Fielding RA, Singh MA: Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol 2001, 90:2341-2350.
12. Senden PJ, Sabelis LW, Zonderland ML, Hulzebos EH, Bol E, Mosterd WL: The effect of physical training on workload, upper leg muscle function and muscle areas in patients with chronic heart failure. Int J Cardiol 2005, 100:293-300.
13. Delagardelle C, Feiereisen P, Autier P, Shita R, Krecke R, Beissel J: Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc 2002, 34:1868-1872.
14. Adamopoulos S, Parissis J, Kroupis C, Georgiadis M, Karatzas D, Karavolias G, Koniavitou K, Coats AJ, Kremastinos DT: Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 2001, 22:791-797.
15. Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT: Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 2002, 39:653-663.
16. Pugh PJ, Jones RD, West JN, Jones TH, Channer KS: Testosterone treatment for men with chronic heart failure. Heart 2004, 90:446-447.
17. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG: "Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005, 7:820-828.
18. Tremblay RR, Dube JY: Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974, 10:599-605.